Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 168

The DOI matches its Crossref record.

Efficacy and Safety of Vaccination of Marrow Transplant Recipients with a Live Attenuated Measles, Mumps, and Rubella Vaccine

Ljungman, P., Fridell, E., Lonqvist, B., Bolme, P., Bottiger, M., Gahrton, G., Linde, A., Ringden, O., Wahren, B.·1989·Journal of Infectious Diseases

Abstract

Long-term immunity to measles, mumps, and rubella viruses was studied in 57 patients after allogeneic bone marrow transplantation. Among patients who were seropositive at the time of transplant, 51% had retained antibodies to measles, 42% had retained antibodies to mumps, and 76% had retained antibodies to rubella 2 y later. There was no difference in the ability to retain antibodies to these viruses between patients with and those without chronic graft-versus-host disease (GVHD). Twenty seronegative patients without active chronic GVHD or ongoing immunosuppressive treatment were vaccinated with a live attenuated trivalent vaccine against measles, mumps, and rubella. No early or late side effects were detected after the vaccinations. The percentages of patients who seroconverted after vaccination were 77%, 64%, and 75% for measles, mumps, and rubella, respectively. Vaccination of transplant recipients with a live attenuated vaccine against measles, mumps, and rubella is safe and usually effective 2 y after transplant if the patients do not have active chronic GVHD or ongoing immunosuppressive treatment at the time of vaccination.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/infdis/159.4.610

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 168

Metadata

Authors
Ljungman, P., Fridell, E., Lonqvist, B., Bolme, P., Bottiger, M., Gahrton, G., Linde, A., Ringden, O., & Wahren, B.
Venue
Journal of Infectious Diseases
Published
1989-04-01
Volume
159
Issue
4
Pages
610-615
ISSN
  • 0022-1899 (ISSN-L)
  • 1537-6613
OpenAlex
W2109840986
Cited by
168
References
0
FWCI
1.37
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Efficacy and Safety of Vaccination of Marrow Transplant Recipients with a Live Attenuated Measles, Mumps, and Rubella Vaccine. https://app.cochat.ai/papers/10.1093/infdis/159.4.610
The paper
Ljungman, P., Fridell, E., Lonqvist, B., Bolme, P., Bottiger, M., Gahrton, G., Linde, A., Ringden, O., & Wahren, B. (1989). Efficacy and Safety of Vaccination of Marrow Transplant Recipients with a Live Attenuated Measles, Mumps, and Rubella Vaccine. Journal of Infectious Diseases. https://doi.org/10.1093/infdis/159.4.610

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.